More and more people are are seeing their doctors at a distance during the pandemic. And this long-awaited shift to telehealth has investors interested. There was already a boom in biotech investing before COVID-19 hit. But WGBH’s Aaron Schachter has more on the latest investor push to put money into all kinds of ways to modernize medicine.